01 1Catalent Micron Technologies, Inc.
02 2Sterling Pharma Solutions Limited
03 1Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.
01 1Levalbuterol L-tartrate
02 3Levalbuterol Tartrate
01 1China
02 1U.S.A
03 2United Kingdom
NDC Package Code : 69988-0045
Start Marketing Date : 2010-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 50384-4188
Start Marketing Date : 2005-03-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50384-4188
Start Marketing Date : 2005-03-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12666-0007
Start Marketing Date : 2008-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
97
PharmaCompass offers a list of Levalbuterol Tartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Levalbuterol Tartrate manufacturer or Levalbuterol Tartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levalbuterol Tartrate manufacturer or Levalbuterol Tartrate supplier.
PharmaCompass also assists you with knowing the Levalbuterol Tartrate API Price utilized in the formulation of products. Levalbuterol Tartrate API Price is not always fixed or binding as the Levalbuterol Tartrate Price is obtained through a variety of data sources. The Levalbuterol Tartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A XOPENEX HFA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of XOPENEX HFA, including repackagers and relabelers. The FDA regulates XOPENEX HFA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. XOPENEX HFA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of XOPENEX HFA manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A XOPENEX HFA supplier is an individual or a company that provides XOPENEX HFA active pharmaceutical ingredient (API) or XOPENEX HFA finished formulations upon request. The XOPENEX HFA suppliers may include XOPENEX HFA API manufacturers, exporters, distributors and traders.
click here to find a list of XOPENEX HFA suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing XOPENEX HFA as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for XOPENEX HFA API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture XOPENEX HFA as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain XOPENEX HFA and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a XOPENEX HFA NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of XOPENEX HFA suppliers with NDC on PharmaCompass.
We have 3 companies offering XOPENEX HFA
Get in contact with the supplier of your choice:
